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Increased stress reactivity: a mechanism speciﬁcally
associated with the positive symptoms of psychotic
disorder
T. Lataster1*, L. Valmaggia2, M. Lardinois1, J. van Os1,2 and I. Myin-Germeys1,3
1 Department of Psychiatry and Psychology, South Limburg Mental Health Research and Teaching Network, EURON, Maastricht University
Medical Centre, The Netherlands
2 Institute of Psychiatry, King’s College London, UK
3 School of Psychological Sciences, University of Manchester, UK
Background. An increased reactivity to stress in the context of daily life is suggested to be an independent risk factor
underlying the positive symptoms of psychotic disorder. The aim of this study was to investigate whether positive
symptoms moderate the association between everyday stressful events and negative aﬀect (NA), known as stress
reactivity. This hypothesis was put to the test in patients with a diagnosis of psychotic disorder.
Method. The Comprehensive Assessment of Symptoms and History (CASH) and the Positive and Negative
Syndrome Scale (PANSS) were used to assess positive and negative symptoms. The experience sampling
method (ESM), a structured diary technique, was used to measure stress reactivity and psychotic symptoms in
daily life.
Results. Higher levels of positive symptoms (CASH: B=0.14, p=0.005 ; PANSS : B=0.05, p=0.000 ; ESM: B=0.03,
p=0.000) and lower levels of negative symptoms (PANSS : B=x0.05, p=0.001) signiﬁcantly moderate the association
between unpleasant events and NA. No signiﬁcant moderating eﬀect was found for CASH negative symptoms.
Moreover, the moderating eﬀect of lifetime and current symptoms on the stress–NA association was signiﬁcantly
larger for those patients with predominantly positive symptoms (CASH: B=0.09, p=0.000 ; PANSS : B=0.08,
p=0.000 ; ESM: B=0.13, p=0.000).
Conclusions. Patients with a ‘psychotic syndrome’ with high levels of positive symptoms and low levels of negative
symptoms show increased reactivity to stress in daily life, indicating that stress reactivity is a possible risk factor
underlying this syndrome.
Received 5 December 2011 ; Revised 30 August 2012 ; Accepted 30 August 2012 ; First published online 31 October 2012
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Introduction
The development of the ﬁfth edition of the Diagnostic
Manual of Mental Disorders has fueled the discussion
about whether schizophrenia is a valid and useful
entity (Kendell & Jablensky, 2003; Keller et al. 2011).
Several authors have favored a combination of a di-
mensional and categorical approach in which patients
have more or less psychopathology rated on several
symptom dimensions (Cuesta & Peralta, 2008 ; van Os,
2009 ; van Os & Kapur, 2009 ; Tandon & Carpenter,
2012). Symptom dimensions may constitute more
homogeneous entities with similar symptom patterns,
etiology, prognosis and possibly treatment. They may
thus be interesting phenotypes both for molecular
genetic studies and for revealing patterns of unique
liability speciﬁcally associated with single symptom
dimensions. Liddle (1987) describes a three-factor sol-
ution (positive, negative and disorganization). Dikeos
et al. (2006) conclude that a ﬁve-factor structure is the
best ﬁt describing the distribution of symptoms across
Kraepelinian divisions (mania, reality distortion, de-
pression, disorganization and negative symptoms).
McGrath et al. (2004, 2009) report nine- and ﬁve-factor
solutions, both including negative and positive
symptom factors. Thus, several symptom dimensions
have been found with factor analyses (Liddle, 1987 ;
Buchanan & Carpenter, 1994 ; Lindenmayer et al. 1994;
McGrath et al. 2004, 2009; Dikeos et al. 2006; Jablensky,
2006 ; Villalta-Gil et al. 2006), with the positive and
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negative symptom dimension being the most promi-
nent.
The theoretical background for this positive–
negative dichotomy dates back to the 1970s to 1980s,
where positive and negative symptoms (Strauss et al.
1974), type I versus type II (Crow, 1980) and deﬁcit-
versus non-deﬁcit schizophrenia (Carpenter et al. 1988)
were ﬁrst described, with coinciding construction
of rating scales assessing this dichotomy (Andreasen
& Olsen, 1982 ; Kay et al. 1987; Kirkpatrick et al.
1989). The positive (or ‘ reality distortion’) symptom
dimension typically constitutes delusions, halluci-
nations and positive formal thought disorder. The
negative (or ‘psychomotor poverty ’) dimension
comprises problems with emotion experience (e.g.
anhedonia, avolition, apathy) and emotion expression
(e.g. blunted/restricted aﬀect). Positive symptoms
typically ﬂuctuate over time periods of hours and
even minutes whereas negative symptoms are thought
to be fairly stable over time.
For the negative symptom dimension, a modest but
consistent correlation has been found with cognitive
impairments (Keefe et al. 2006; Dominguez et al. 2011;
Lataster et al. 2012). Reports on possible risk factors for
the positive symptoms of psychosis are less consistent.
Aberrations in social cognition have been suggested.
However, mixed results have been reported (Freeman,
2007 ; Versmissen et al. 2007; Lincoln et al. 2010).
Alternatively, increased reactivity to the environment
has been suggested.
It is well established that environmental stresses,
such as life events (Bebbington et al. 1996), childhood
trauma (Bebbington et al. 2004; Janssen et al. 2004;
Varese et al. 2012) or bullying (Lataster et al. 2006), play
a role in the development of psychotic disorder.
Neuroticism questionnaires are often used to assess an
individual’s stress sensitivity, and it has been shown
that people with schizophrenia report higher levels of
neuroticism (Horan et al. 2005). Moreover, neuroticism
scores have been associated with positive symptoms
(Lysaker et al. 2003; Barrantes-Vidal et al. 2009)
and with increased risk for psychosis at both the
clinical and subclinical level (van Os & Jones, 2001 ;
Krabbendam et al. 2002). In one experimental study
using a speech stress task, higher levels of trait
arousability (an individual’s emotional and physio-
logical reactivity to novel events) were found to
be associated with positive and aﬀective symptoms
(Dinzeo et al. 2004). However, these ﬁndings were only
partly replicated (i.e. a signiﬁcant association for
aﬀective but not positive symptoms) in a later study
(Dinzeo et al. 2008). Docherty et al. (2009) found that
trait arousability moderated the association between
life events and positive symptoms, with a signiﬁcant
association between life events and positive symptoms
for patients with high but not low levels of trait
arousability. It has been suggested, however, that the
subtler daily hassles also impact on psychosis out-
come. In a series of studies by Myin-Germeys and
colleagues (for a review see Myin-Germeys & van Os,
2007), an attempt was made to assess daily life stress
reactivity in an ecologically valid manner using a
structured diary technique, the experience sampling
method (ESM). It was shown that patients with psy-
chosis and their ﬁrst-degree relatives are increasingly
emotionally reactive to stress in the context of daily life
(Myin-Germeys et al. 2001). Moreover, it was found
that subtle everyday stresses are accompanied by an
exacerbation of psychotic symptoms (Myin-Germeys
et al. 2005). The results of two more recent studies
further contribute to the notion that stress reactivity
is, in part, a genetically determined risk factor
for psychotic disorder, and more speciﬁcally for the
positive symptom dimension (Lataster et al. 2009,
2010).
The aim of this study was to investigate whether
the positive and negative symptom dimensions of
psychotic disorder moderate the association between
everyday stressful events and negative aﬀect (NA),
known as stress reactivity. Based on ﬁndings from
previous studies, we hypothesized that high levels of
positive symptoms would be speciﬁcally associated
with this reactivity to stress in daily life.
Method
Subjects
The sample consisted of 77 patients with a diagnosis
of a non-aﬀective psychotic disorder. In selected rep-
resentative geographical areas in The Netherlands and
Belgium, patients were identiﬁed through representa-
tive clinicians working in regional psychotic disorder
services whose case loads were screened for inclusion
criteria. Subsequently, a group of patients presenting
consecutively at these services as either out-patients or
in-patients were recruited for the study.
Two trained research assistants and two psycho-
logists conducted all of the interviews. The Positive
and Negative Syndrome Scale (PANSS; Kay et al. 1987)
was used to assess current psychiatric symptoms. The
PANSS interviewers took part in an inter-rater re-
liability evaluation as part of a large Dutch national
project on psychotic disorder (Korver et al. 2012),
where intra-class correlations (ICCs) were calculated
based on scores of 16 randomly selected raters who
rated four videotaped interviews (ICC PANSS positive
subscale score : 0.96 ; ICC PANSS negative subscale
score : 0.91). The Comprehensive Assessment of
Symptoms and History (CASH; Andreasen et al. 1992)
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was completed to assess lifetime symptom history,
yielding DSM-IV diagnoses (APA, 1994).
Inclusion criteria were : (1) lifetime occurrence
of non-aﬀective psychotic symptoms, according to
DSM-IV criteria, (2) age 16–60 years and (3) suﬃcient
command of the Dutch language. Exclusion criteria
were : (1) brain disease, (2) history of head injury
with loss of consciousness, (3) substance-related
psychosis and (4) psychosis with a known organic
cause. Written informed consent, conforming to local
ethics committee guidelines, was obtained from all
subjects.
ESM
The ESM was used to measure the emotional reaction
to stress in the ﬂow of daily life, called ‘stress
reactivity ’. ESM is a within-day, momentary self-
assessment technique (Myin-Germeys et al. 2009;
Oorschot et al. 2009). Subjects received a digital wrist-
watch and self-assessment forms collated in a booklet
for each day. Ten times a day on 6 consecutive days,
the watch emitted a signal (beep) at unpredictable
moments between 07:30 and 22:30 hours. Subjects
were asked to report immediately after each beep their
thoughts, current context (activity, persons present,
location), appraisals of the current situation, and
mood. All self-assessments were rated on seven-point
Likert scales. The ESM procedure was explained to the
participants in an initial brieﬁng session of about
45 min, where a practice form was completed to con-
ﬁrm that subjects were able to understand all ques-
tions and the seven-point Likert scale format. To
minimize memory distortion, subjects were instructed
to complete their reports immediately after the beep,
and to record the time at which they completed the
form. In the actual sampling week, participants were
called by research staﬀ to further ensure that they
were complying with the instructions. The time the
watch emitted a signal was compared to the time
participants completed the report to ensure reliability
of the completed reports. All reports completed more
than 15 min after the beep were excluded from the
analyses because previous research (Delespaul, 1995)
has shown that reports completed after this interval
are less reliable and consequently less valid. For the
same reason, subjects with less than 20 valid reports
(out of 60) were excluded from the analysis
(Delespaul, 1995).
Assessment of mood and stress
Measures of mood and stress were derived from the
ESM reports as follows.
Assessment of mood
ESM NA was assessed at each beep with six mood-
related adjectives (down, guilty, insecure, lonely,
anxious, angry/irritated) rated on seven-point Likert
scales (1=not at all, 7=very). Mean scores on these six
mood questions were used as a measure of NA in the
analyses (Cronbach’s a=0.85).
Assessment of stress
In accordance with previous work, stress was con-
ceptualized as the subjectively appraised stressfulness
of distinctive events (event-related stress) (Lataster
et al. 2010). To measure event-related stress, the subject
was asked to report, after each beep, the most im-
portant event that had happened between the current
and the previous report. This event was subsequently
rated on a bipolar Likert scale (x3=very unpleasant,
0=neutral, 3=very pleasant). The responses were
recoded to allow high scores to reﬂect high levels
of stress (x3=very pleasant, 0=neutral, 3=very un-
pleasant).
Assessment of symptoms
Current positive and negative symptoms
All subjects were assessed with the PANSS (Kay et al.
1987) at the end of the ESM week (assessment period
of 2 previous weeks, thereby also covering the ESM
week). The PANSS comprises positive, negative and
general symptom scales. For the present study we
used the positive and negative symptom scales, each
of which include seven items scored on a seven-point
scale (1=absent, 7=extreme). The mean scores
on both the positive and negative scales were used.
In addition, the momentary ESM items ‘I feel
suspicious ’, ‘ I see things’ and ‘I hear voices ’ were
combined into one mean ESM positive symptom
score.
Lifetime positive and negative symptoms
The lifetime occurrence of positive and negative
symptoms of schizophrenia was measured with the
CASH (Andreasen et al. 1992). A mean score on CASH
section 6 (delusions) and section 7 (hallucinations)
formed the positive symptom score (Cronbach’s
a=0.75) used for the analyses. The negative symptom
variable (Cronbach’s a=0.60) comprised scores on
items assessing lifetime emotion experience (section 11
‘apathy’, section 12 ‘anhedonia ’) and current prob-
lems with emotion expression as observed by
the interviewer (section 15 ‘observation of ﬂattened
aﬀect ’). All scores on sections 11, 12 and 15 used
for the negative symptom variable were recoded to
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match the 0/1 coding of the items that comprised
the positive symptom variable (0=absent and
1–5=present).
Analyses
ESM data have a multi-level structure : multiple ob-
servations (level 1) are nested within subjects (level 2),
who were in some cases (n=8) part of sib pairs (level
3). To take the three-level grouping structure of the
data (ESM beep level observations, subject, sib pair)
into account, multi-level random regression analysis
(Snijders & Bosker, 1999) was applied in Stata version
11.2 (StataCorp, 2009), using the XTMIXED command.
Mixed models are characterized as containing both
ﬁxed and random eﬀects. All analyses were conducted
with standardized dependent variables using the STD
command in Stata, yielding standardized values for
each speciﬁed variable with mean (0) and standard
deviation (1).
Association between stress reactivity and positive
and negative symptoms
Multi-level linear regression analyses were conducted
to examine the moderating eﬀect of the positive and
negative symptoms of schizophrenia, measured with
the CASH, PANSS and ESM, on the association be-
tween daily life event-related stress and NA. For these
analyses, NA was entered in the model as the depen-
dent variable and mean scores on CASH and PANSS
positive and negative symptoms and ESM positive
symptoms, the ratings on event-related stress and
their interactions (stressrsymptoms) were the inde-
pendent variables (general model : NA=B0+B1event-
stress+B2symptoms+B3event-stressrsymptoms+
residual). The interaction term was the focus of these
analyses because the hypothesis required testing
whether positive and negative symptoms moderated
the association between stressful events and NA in-
tensity. In the case of signiﬁcant interaction eﬀects,
stratiﬁed analyses were performed using the MARGINS
command in Stata to calculate the eﬀect sizes of the
interactions between symptoms (see the section on
sensitivity analyses for details on how symptom
scores were stratiﬁed) on the one hand and stress on
NA on the other.
Sensitivity analyses
To test whether the moderating eﬀect of positive
symptoms on the association between event-stress and
NAwas stronger in those subjects with predominantly
positive symptoms, the multi-level linear regression
analyses were repeated comparing those subjects
who scored high on positive symptoms and low on
negative symptoms assessed with the CASH (CASH
high positive : 1 if positive symptom score o0.5 and
negative symptom score <0.5, n=14; 0 in all other
cases, n=50) and the PANSS (PANSS high positive : 1
if positive symptom score o2 and negative symptom
score <2, n=13; 0 in all other cases, n=51). For the
PANSS, we tested whether moderating eﬀects of
negative symptoms on the stress–NA association was
diﬀerent for those subjects with high negative and low
positive symptoms (PANSS high negative : 1 if nega-
tive symptom score o2 and positive symptom score
<2, n=7 ; 0 in all other cases, n=57). For the ESM-
psychosis variable, stratiﬁcation was chosen at the
beep level, comparing the association between event-
stress and NA on those beeps where scores on ESM
psychosis were high (scoreo2.5, n=224 beeps) versus
all beeps where ESM psychosis was low (score <2.5,
n=2342 beeps).
To test the relative independence of the moderating
eﬀect of positive symptoms on the stress–NA associ-
ation, two multi-level linear regression models were
ﬁtted (for CASH lifetime and PANSS current
symptoms) with the stressrpositive symptoms and
stressrnegative symptoms interaction terms entered
simultaneously in the model.
Results
Subjects and descriptives
The ﬁnal sample consisted of 77 patients ; of these, ﬁve
dropped out of the study before ﬁnishing the ESM re-
ports and 72 completed the ESM reports. A further
eight subjects were excluded because they had
less than 20 valid ESM self-reports or a large number
of missing values on event-related stress (also
leading to less than 20 valid ESM reports for the
analyses ; i.e. 64 subjects remained), yielding a total of
2568 beeps with a mean of 40 beeps per subject.
Demographic and clinical statistics of the sample are
shown in Table 1, and the mean scores for the inde-
pendent and dependent variables are shown in
Table 2.
Association between stress reactivity and positive
and negative psychotic symptoms
The multi-level random regression analyses conduc-
ted to examine the associations between CASH,
PANSS and ESM positive and negative symptom
scores on the one hand and the association between
stress and NA (i.e. ‘ stress reactivity ’) on the other,
showed signiﬁcant positive interaction eﬀects for cur-
rent (PANSS and ESM) and lifetime (CASH) positive
symptoms, and a signiﬁcant negative or inverse
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interaction eﬀect for current negative symptoms as
measured with the PANSS. No signiﬁcant interaction
eﬀect was found for lifetime negative symptoms as
measured with the CASH (Table 3).
Sensitivity analyses
Stratiﬁed analyses showed that the association be-
tween event-stress and NA was stronger for those
subjects who scored high on CASH, PANSS or ESM
positive symptoms and low on negative symptoms
(Table 3). By contrast, subjects who scored high on
PANSS negative symptoms but low on PANSS posi-
tive symptoms showed a weaker association between
event-stress and NA (Table 3).
The multi-level linear regression models with
the two interactions (stressrpositive symptoms and
stressrnegative symptoms) entered simultaneously
in the model showed that the moderating eﬀect of
positive symptoms on the stress–NA association re-
mains signiﬁcant after controlling for the moderating
eﬀect of negative symptoms on this association [CASH
lifetime : B=0.14, 95% conﬁdence interval (CI) 0.045–
0.238, p=0.004 ; and PANSS current : B=0.06, 95% CI
0.028–0.082, p=0.000], supporting the relative inde-
pendence of the stressrpositive symptom interaction
in the NA model.
The results of these stratiﬁed analyses showing ef-
fect sizes of stress on NA for the diﬀerent subject cat-
egories (e.g. ‘high positive ’) are shown in Figs 1 and 2.
Table 1. Demographic and clinical characteristics
Age (years)*, mean (S.D.), range 29.4 (9.3), 17–56
Gendera, n (%)
Male 42 (66)
Female 22 (34)
Civil statusa, n (%)
Married or living together 13 (20)
Divorced 3 (5)
Never married 48 (75)
Work situationa, n (%)
Working 12 (19)
Unemployed 44 (69)
School/education 8 (12)
Educationa, n (%)
Secondary school 6 (9)
Higher education 58 (91)
PANSS sum score (min–max), mean (S.D.), range 47.9 (12.6), 30–97
Positive syndrome scale (7–49), mean (S.D.), range 12.3 (4.7), 7–26
Negative syndrome scale (7–49), mean (S.D.), range 10.4 (4.0), 5–23
General syndrome scale (16–112), mean (S.D.), range 25.2 (6.4), 16–50
Age at ﬁrst psychotic episode (years)a, mean (S.D.), range 23.1 (7.2), 13–44
Illness duration (years), mean (S.D.), range 6.2 (6.9), 1–40
Number of episodesa, mean (S.D.), range 2.3 (1.8), 1–12
CASH DSM-IV Axis I diagnosis lifetime (n)
Schizophrenia 40
Schizo-aﬀective disorder 9
Psychotic disorder NOS 7
Brief psychotic disorder 5
Delusional disorder 2
Schizophreniform disorder 1
PANSS, Positive and Negative Syndrome Scale ; CASH, Comprehensive
Assessment of Symptoms and History ; NOS, not otherwise speciﬁed ; S.D., standard
deviation.
a None of these variables were signiﬁcantly associated with the main outcome
(negative aﬀect), and were therefore not included as confounders in the regression
models.
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Discussion
In this study, a direct moderating eﬀect of current and
lifetime positive symptoms on the association between
stressful events and NA (i.e. stress reactivity) was
found in the context of daily life. No such association
was found for lifetime negative symptoms, and cur-
rent negative symptoms as measured with the PANSS
were even found to be negatively associated with
stress reactivity (i.e. higher levels of current negative
symptoms showing a weaker moderating eﬀect on the
stress–NA association). More important, the results
show that the association is particularly strong for
those subjects who have predominantly positive
symptoms.
Findings
The ﬁnding that high levels of positive symptoms
moderate the stress–NA association is in accordance
with previous studies showing an association between
trait arousability and positive symptom scores
(Dinzeo et al. 2004; Docherty et al. 2009). It also extends
the ﬁnding of a momentary stress-induced increase
in the intensity of positive psychotic experiences
(Myin-Germeys et al. 2005) to a global pattern of
increased stress reactivity in participants showing
higher levels of positive symptoms. Moreover, the
ﬁndings of this study suggest that negative symptoms
have a signiﬁcant beneﬁcial eﬀect on stress reactivity
(i.e. higher levels of negative symptoms associated
with a weaker eﬀect of stress on NA). This is in ac-
cordance with the study by Scholten et al. (2006)
showing that high activity of the Behavioral Inhibition
System (BIS), a neural system that is sensitive to cues
of threat, is associated with low levels of negative
symptoms, and a more recent ﬁnding that patients
with high levels of negative symptoms have a lower
risk for post-traumatic stress disorder (Strauss et al.
2011). The ﬁndings of the current study ﬁt within an
aﬀective pathway to psychosis, suggesting that altered
stress reactivity may be an independent and speciﬁc
vulnerability marker for the positive symptom di-
mension of psychosis (Myin-Germeys & van Os, 2007).
An alternative explanation for the current results is
that positive symptoms (delusions and hallucinations)
increase the emotional reactivity to stress in daily life,
rather than the other way around. However, post-hoc
analysis showed no signiﬁcant main eﬀect of CASH
and PANSS positive symptoms on event-stress.
Similarly, the use of antipsychotic medication or pres-
ence of depression in these patients may have inﬂu-
enced the results, especially those regarding negative
symptoms. However, controlling for these possible
confounders did not substantially change the results.
How might stress reactivity contribute to psychosis?
Biological mechanisms
There are several biological models that can account
for the relationship between positive psychotic symp-
toms and increased emotional reactivity to stress.
A possible interpretation of the association is that
minor stressors cause an increase in psychosis inten-
sity. As this eﬀect would suggest an enduring increase
in the behavioral response to environmental stress,
it could be described as behavioral sensitization
(Myin-Germeys et al. 2005). Accordingly, post-hoc
analyses showed that those patients with a longer
Table 2. Mean scores on the (non-standardized) dependent and independent variables
Measure n Mean S.D. Range
Stress
Event-related stress 64 x1.35 1.7 x3 to+3
Mood
Negative aﬀect (NA) 64 1.87 1.1 1–7
CASH lifetime symptoms Association with ESM positive symptoms [B (95% CI), p]
Positive symptoms 64 0.38 0.2 0.1–0.9 0.45 (–0.007 to 0.912), 0.053
Negative symptoms 64 0.44 0.3 0–0.9
PANSS current symptoms Association with ESM positive symptoms [B (95% CI), p]
Positive symptoms 62 1.76 0.7 1–3.7 0.32 (0.169–0.478), 0.000
Negative symptoms 62 1.49 0.5 1–3.3
ESM positive symptoms 64 1.35 0.73 1–7
CASH, Comprehensive Assessment of Symptoms and History ; PANSS, Positive and Negative Syndrome Scale ;
ESM, experience sampling method ; B, standardized regression coeﬃcient ; CI, conﬁdence interval ; n, number of subjects
included in the analyses ; S.D., standard deviation.
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illness duration (as a proxy for longer exposure to
stress, coded as 0=illness duration <5 years and
1=illness durationo5 years) show larger increases in
NA with everyday stressful events (i.e. a diﬀerence
in eﬀect size of 0.06, x2=10.3, p=0.001). It has been
suggested that exposure to environmental stressors
resulting in a chronic heightened glucocorticoid
release may cause permanent changes in the
hypothalamic–pituitary–adrenal (HPA) axis. In line
with this, it was shown that siblings of patients with a
psychotic disorder have higher diurnal cortisol levels
and increased cortisol reactivity to negative daily
events relative to controls (Collip et al. 2011).
Moreover, there is evidence suggesting that cortisol
secretion is increased in patients prior to the onset of a
ﬁrst psychotic episode (Walker et al. 2010). Such a
Table 3. Multi-level linear regression analyses assessing the moderating eﬀect of CASH lifetime positive and negative symptoms, PANSS
current positive and negative symptoms, and ESM momentary positive symptoms on the association between event-stress and NA (i.e.
stress reactivity)
n B 95% CI p x2
CASH positive symptoms
Main eﬀect of event-stress on NA 64 0.05 0.007–0.092 0.022
Main eﬀect of positive symptoms on NA 64 1.5 0.561–2.45 0.002
Event-stressrpositive symptoms in the model of NA 64 0.14 0.042–0.232 0.005 8.0
Stratiﬁcation : CASH predominantly positive symptoms (n=13, score : 1, n=51, score : 0)
Main eﬀect of event-stress on NA 64 0.08 0.065–0.103 0.000
Main eﬀect of positive symptoms on NA 64 0.55 0.111–0.992 0.014
Event-stressrpositive symptoms in the model of NA 64 0.09 0.050–0.129 0.000 19.98
CASH negative symptoms
Main eﬀect of event-stress on NA 64 0.10 0.066–0.142 0.000
Main eﬀect of negative symptoms on NA 64 0.12 x0.614 to 0.844 0.757
Event-stressrnegative symptoms in the model of NA 64 0.004 x0.070 to 0.078 0.914 0.01
PANSS positive symptoms
Main eﬀect of event-stress on NA 62 0.02 x0.029 to 0.074 0.399
Main eﬀect of positive symptoms on NA 62 0.36 0.089–0.629 0.009
Event-stressrpositive symptoms in the model of NA 62 0.05 0.021–0.075 0.000 12.34
Stratiﬁcation : PANSS predominantly positive symptoms (n=7, score : 1, n=57, score : 0)
Main eﬀect of event-stress on NA 62 0.09 0.068–0.109 0.000
Main eﬀect of positive symptoms on NA 62 0.55 0.111–0.997 0.014
Event-stressrpositive symptoms in the model of NA 62 0.08 0.031–0.105 0.000 12.95
PANSS negative symptoms
Main eﬀect of event-stress on NA 62 0.19 0.138–0.238 0.000
Main eﬀect of negative symptoms on NA 62 x0.06 x0.399 to 0.275 0.720
Event-stressrnegative symptoms in the model of NA 62 x0.05 x0.088 tox0.022 0.001 10.91
Stratiﬁcation : PANSS predominantly negative symptoms (n=7, score : 1, n=55, score :0)
Main eﬀect of event-stress on NA 62 0.12 0.099–0.134 0.000
Main eﬀect of negative symptoms on NA 62 0.16 x0.436 to 0.757 0.599
Event-stressrnegative symptoms in the model of NA 62 x0.08 x0.146 tox0.023 0.007 7.25
ESM momentary positive symptoms
Main eﬀect of event-stress on NA 64 0.04 0.010–0.070 0.009
Main eﬀect of positive symptoms on NA 64 0.49 0.436–0.536 0.000
Event-stressrpositive symptoms in the model of NA 64 0.03 0.015–0.053 0.000 12.70
Stratiﬁcation : ESM momentary ‘high ’ versus ‘ low’ positive symptoms (n=224 beeps, score : 1, n=2342 beeps, score : 0)
Main eﬀect of event-stress on NA 64 0.09 0.074–0.108 0.000
Main eﬀect of positive symptoms on NA 64 0.84 0.704–0.981 0.000
Event-stressrpositive symptoms in the model of NA 64 0.13 0.069–0.190 0.000 17.62
CASH, Comprehensive Assessment of Symptoms and History ; PANSS, Positive and Negative Syndrome Scale ;
ESM, experience sampling method ; NA, negative eﬀect ; CI, conﬁdence interval ; n, number of subjects included in the analyses ;
B, standardized regression coeﬃcient. For the stratiﬁed analyses the B values represent the magnitude of the diﬀerence in
eﬀect between the high (1) versus low category (0).
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stress-induced dysregulation of the HPA axis may
give rise to increased subcortical dopamine (DA)
receptor densities and DA release and may underlie
the dopaminergic abnormalities that are generally
thought to be involved in psychosis (van Winkel et al.
2008; Walker et al. 2008). Additionally, a dysregulated,
subcortical hyperdopaminergic state may lead to
stimulus-independent release of DA, which may take
over the normal process of contextually driven
salience attribution and lead to aberrant assignment
of salience to external objects and internal rep-
resentations (Kapur, 2003 ; Howes & Kapur, 2009). In
accordance with this, there is evidence for increased
dopamine synthesis in patients prior to onset of the
ﬁrst psychotic episode (Howes et al. 2011).
Psychological mechanisms
Psychological models suggest that triggering events
may lead to the development of positive psychotic
symptoms. These models posit that victimization
experiences may lead to the formation of negative
schemas about the self and the world (e.g. beliefs
about the self as vulnerable to threat, or about others
as dangerous) that facilitate external attributions,
which may lead to the development of paranoid de-
lusions (Bentall et al. 2001; Garety et al. 2001, 2007).
Additionally, several aﬀective processes, in particular
neuroticism, depression and anxiety, have been hypo-
thesized to play a role in the formation of psychotic
symptoms (Bentall et al. 2001; Birchwood et al. 2005).
Although ﬁndings on the association between neuro-
ticism and speciﬁc symptoms are inconclusive (Horan
0.15
0.10
0.05
0
CASH high
positive
PANSS high
positive
PANSS high
negative
ESM high v.
low
psychosis
low (0) category
high (1) category
χ2 =19.98**
χ2 =12.95**
χ2 = 7.25*
χ2 = 17.62**
0.20
0.25
Ef
fe
ct
 s
iz
e 
of
 e
ve
nt
-s
tr
es
s 
on
 N
A
a
Fig. 1. Stratiﬁed analyses assessing the association between
stress and negative eﬀect (NA) for subjects with
predominantly positive symptoms on the Comprehensive
Assessment of Symptoms and History (CASH), the Positive
and Negative Syndrome Scale (PANSS) or the experience
sampling method (ESM) and predominantly negative
symptoms on the PANSS compared to subjects with low
scores respectively. Note that no stratiﬁed analyses were
performed for CASH negative symptoms because the main
interaction was not signiﬁcant. ‘CASH high positive ’ high (1)
category : 95% conﬁdence interval (CI) 0.140–0.208, p=0.000 ;
‘CASH high positive ’ low (0) category : 95% CI 0.065–0.103,
p=0.000 ; ‘PANSS high positive ’ high (1) category : 95% CI
0.126–0.188, p=0.000 ; ‘PANSS high positive ’ low (0)
category : 95% CI 0.068–0.109, p=0.000 ; ‘PANSS high
negative ’ high (1) category : 95% CIx0.027 to 0.091,
p=0.293 ; ‘PANSS high negative ’ low (0) category : 95% CI
0.099–0.134, p=0.000 ; ‘ESM psychosis high ’ : 95% CI 0.162–
0.279, p=0.000 versus ‘ESM psychosis low’ : 95% CI 0.074–
0.108, p=0.000. a These are the ‘absolute ’ B values
(regression coeﬃcients) per category as opposed to the B
values representing the magnitude of the diﬀerence in eﬀect
between the high versus low category as presented in Table 3.
* p<0.01, ** p<0.001.
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Fig. 2. The association between event-stress and negative
eﬀect (NA) for the ‘high ’ and ‘ low’ symptom categories of
(a) Comprehensive Assessment of Symptoms and History
(CASH) lifetime positive symptoms and (b) Positive and
Negative Syndrome Scale (PANSS) current positive
symptoms.
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et al. 2008), some studies suggest a speciﬁc association
with the positive symptom dimension (van Os &
Jones, 2001 ; Krabbendam et al. 2002; Lysaker et al.
2003; Horan et al. 2005; Laroi et al. 2006). Moreover,
one study reported a moderating eﬀect of neuroticism
on the association between positive schizotypy and
measures of psychopathology and functioning in a
non-clinical sample (Barrantes-Vidal et al. 2009). The
results of the current study would suggest that small
daily events trigger the type of aﬀective disturbances
that may facilitate the process whereby anomalous
experiences become psychotic symptoms.
Clinical implications
The current results suggest that stress reactivity may
be a vulnerability marker underlying the positive
symptoms of psychosis. Clearly, these results are still a
long way from oﬀering direct therapeutic insight.
However, if stress reactivity can truly be considered a
speciﬁc area of vulnerability, it may be useful to tailor
treatment aimed at reducing reactivity to stress in
daily life. One possible way to do so is by reducing
stress in the social environment of the patient
(Pilling et al. 2002). Training patients to apply self-
relaxation or self-distraction techniques seems to im-
prove emotional well-being in chronic schizophrenia
patients but not in early psychosis (Hodel et al. 1998).
Previous studies have shown that cognitive behavioral
therapy (CBT) reduces psychotic symptoms (Pilling
et al. 2002) and also reduces distress caused by psy-
chotic symptoms (Valmaggia et al. 2005), and there are
some studies suggesting that it might reduce relapse
rates (Gumley et al. 2006). The results of a more recent
study suggest, however, that CBT helps in depression
and emotional distress but not in psychosis relapse
(Garety et al. 2008). Extending this therapy in such
a way that treatment is additionally focused on
emotional reactivity to stress in daily life may thus
have positive eﬀects on depression and distress
that are experienced with psychotic symptoms. Of
interest, the newest generation of CBT puts high em-
phasis on the context (hence the name ‘contextual
CBT’), and uses stress-reduction techniques (e.g.
elements from mindfulness or acceptance and com-
mitment therapy) to create a more ‘open, active, and
aware approach to living’ (for a review see Hayes et al.
2011).
Methodological issues
The results should be viewed in the light of several
methodological issues. First, the ESM measurements
are based on subjective reports. Therefore, it can be
argued that the results are not psychometrically
precise. However, although subjective reports are
considered less reliable (e.g. do all subjects interpret or
answer the questions identically?), previous research
indicates that subjective reports can be valid, and that
the validity of objective reports should not be taken for
granted (Strauss, 1994).
Second, ESM is a daily life assessment technique
in which subjects have to comply with a paper-and-
pencil diary protocol without the researcher being
present. However, some authors have cast doubt on
the reliability and subject compliance in paper-and-
pencil ESM studies, favoring the use of electronic
devices (Stone et al. 2002; Broderick et al. 2003). In a
comparative study, Green et al. (2006) concluded that
both methods yielded similar results. In addition,
a study using a signal-contingent random time
sampling procedure with multiple observations per
day, similar to the protocol used in the current study,
found evidence that underscores the validity of the
paper-and-pencil random time self-report data in the
current study (Jacobs et al. 2005). Third, it is possible
that our negative ﬁnding for lifetime negative symp-
toms is a consequence of the way these symptoms
were assessed with the CASH, with a limited set of
items. It has been suggested that the assessment of
negative symptoms with the instruments available to
date is complex and often unreliable (Horan et al. 2006;
Blanchard et al. 2011) because they rely heavily
on interviewer observations and on the patient’s re-
ﬂective capacity. Following this, our positive results
showing a signiﬁcant, but inverse, eﬀect of current
negative symptoms in the stress–NA association
should be interpreted with caution. Fortunately, more
reliable negative symptom measures are currently
being developed, taking into account the patient’s
subjective needs and, for example, assessing in-the-
moment ﬂattening of aﬀect by telling a joke and ob-
serving the patient’s response to it (i.e. the Clinical
Assessment Interview for Negative Symptoms;
Blanchard et al. 2011).
Finally, stress reactivity has been deﬁned as the
emotional reaction to subjective stress. The current
results are based on cross-sectional analyses and
therefore the possibility of reverse causality cannot be
excluded. There is a possibility that increased NA or
increased levels of positive or negative symptoms in-
ﬂuence the subjective appraisal of the environment.
However, the individual would still experience psy-
chosis or distress with an environmental event.
Conclusions
The results of the present study show a direct moder-
ating eﬀect of the positive symptoms of psychosis on
the association between stressful events and NA in the
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everyday life of patients with a psychotic disorder (i.e.
stress reactivity). This association seems to be par-
ticularly strong for those subjects who have pre-
dominantly positive symptoms rather than negative
symptoms. This study shows that stress reactivity is a
core risk factor within the aﬀective pathway leading to
a psychotic syndrome with high levels of positive
symptoms.
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